GRN No. 1163

A preparation containing two bacteriophages (phage) specific to Salmonella enterica

• Intended Use: Intended for use as an antimicrobial on the surface of raw poultry at levels up to 2 x 10⁸ plaque forming units (PFU)/g of food.
• Basis: Scientific procedures
• Notifier: Cytophage Technologies inc.
• Notifier Address: 26 Henlow Bay; Winnipeg, MB; R3Y 1G4; Canada
• FDA's Letter: Pending